Research and Practice in Thrombosis and Haemostasis
Издатель: Elsevier · ISSN 2475-0379 · 89 статей
- Early outcomes after venous thromboembolism in Hispanic and non-Hispanic patients: insights from the Registro Informatizado de Enfermedad TromboEmbólica Registry
- Association between coffee consumption and risk of recurrent venous thromboembolism – Results from the Trøndelag Health Study and Tromsø Study
- Elevated relative risk of venous thrombosis in young adults with colorectal cancer: a global cohort study
- Quantitative point-of-care testing in patients treated with apixaban
- DOACs in the Emergency Department: When No Monitoring Becomes a Clinical Challenge
- Mouse models to study von Willebrand factor in thrombosis: a scoping review
- Association of dual-pathway antithrombotic therapy with primary patency after iliofemoral venous stenting: a multicenter cohort study
- Inhibitor relapse after successful immune tolerance induction in children with severe hemophilia A: risk factors and development of a prediction nomogram
- Interplatform discrepancies in anticardiolipin and anti-beta-2-glycoprotein-I testing and their impact on antiphospholipid syndrome assessment: a retrospective-prospective observational study
- Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis
- Association of the sarcopenia index based on the serum creatinine to cystatin C ratio and genetic risk with venous thromboembolism: a population-based cohort study
- A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin
- Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban
- Long-term outcomes of antithrombotic treatment for retinal vein occlusion
- Bleeding events in people with hemophilia B on prophylactic factor IX treatment: a systematic review and meta-analysis
- Evolutionary constraint and population variation across coagulation genes
- Prevalence of qualitative platelet disorders in adolescents and young adults with heavy menstrual bleeding: a single center experience
- Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study
- Reevaluating hypercoagulability in the portal vein and the impact of transjugular intrahepatic portosystemic shunt on platelet activation in cirrhosis
- A buffer-positive serotonin release assay pattern is associated with increased mortality in HIT: a retrospective cohort study
- Correlation of thrombus immune cell composition and clinical outcome in acute ischemic stroke: an MR CLEAN-NO IV substudy
- Risk of cancer following venous thromboembolism in patients with a history of stroke: a population-based cohort study
- Peri-interventional use of rondaptivon pegol (BT200) in thrombocytopenic patients with type 2B von Willebrand disease with implications for wound healing and therapy for acute bleeding
- Splenectomy corrects bleeding phenotype in gray platelet syndrome with a novel NBEAL2 variant
- AngioJet rheolytic thrombectomy under superior vena cava filter protection for acute upper extremity deep vein thrombosis in patients with cancer: a single-center, retrospective analysis
- A targeted mass spectrometric assay for quantitative detection of fibrinogen in plasma
- Identifying the international need for Antithrombotic Stewardship in perioperative anticoagulation management
- Risk of severe abnormal uterine bleeding in Korean women initiating direct oral anticoagulants: a nationwide population-based cohort study
- Activation of coagulation by trypsin
- Targeted long-read sequencing identifies a novel 1.3 kb FGG deletion associated with variable bleeding and thrombotic phenotypes in hypofibrinogenemia